ArunA Biomedical and Open Biosystems will launch the complete and fully validated induced pluripotent stem cell (viPS) kits containing all the tools and reagents necessary to generate patient and disease specific cell lines for use in research applications in early April 2009.
According to ArunA, the viPS product offerings will include two kit formats and additional supplemental kits designed exclusively by the companies. The products will be marketed by Open Biosystems.
Steven Stice, co-founder and CSO of ArunA, said: “These kits are consistent with the scientific vision of our company. They exemplify ArunA’s commitment to making stem cell research easier thereby enabling investigators the opportunity to make faster advances in the stem cell field.
“Induced pluripotent cells generated from these kits can help find cures for many genetic disorders ranging from certain types of Alzheimer’s to Huntington’s disease.”